U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Subarachnoid hemorrhage

MedGen UID:
11625
Concept ID:
C0038525
Disease or Syndrome
Synonyms: Hemorrhage, Subarachnoid; Hemorrhages, Subarachnoid; SAH (Subarachnoid Hemorrhage); SAHs (Subarachnoid Hemorrhage); Subarachnoid Hemorrhage; Subarachnoid Hemorrhages
SNOMED CT: SAH - Subarachnoid hemorrhage (21454007); Subarachnoid intracranial hemorrhage (21454007); Subarachnoid hemorrhage (21454007)
 
HPO: HP:0002138
Monarch Initiative: MONDO:0005099

Definition

Hemorrhage occurring between the arachnoid mater and the pia mater. [from HPO]

Conditions with this feature

Glycogen storage disease, type II
MedGen UID:
5340
Concept ID:
C0017921
Disease or Syndrome
Pompe disease is classified by age of onset, organ involvement, severity, and rate of progression. Infantile-onset Pompe disease (IOPD; individuals with onset before age 12 months with cardiomyopathy) may be apparent in utero but more typically onset is at the median age of four months with hypotonia, generalized muscle weakness, feeding difficulties, failure to thrive, respiratory distress, and hypertrophic cardiomyopathy. Without treatment by enzyme replacement therapy (ERT), IOPD commonly results in death by age two years from progressive left ventricular outflow obstruction and respiratory insufficiency. Late-onset Pompe disease (LOPD; including: (a) individuals with onset before age 12 months without cardiomyopathy; and (b) all individuals with onset after age 12 months) is characterized by proximal muscle weakness and respiratory insufficiency; clinically significant cardiac involvement is uncommon.
Aneurysm, intracranial berry, 2
MedGen UID:
325285
Concept ID:
C1837894
Disease or Syndrome
Intracranial berry aneurysms are saccular outpouchings of the intracranial arteries, most commonly at arterial bifurcations, characterized by arterial wall remodeling. Most cases of ruptured intracranial berry aneurysms result in a subarachnoid hemorrhage, associated with high morbidity and mortality (summary by van der Voet et al., 2004). For a discussion of genetic heterogeneity of intracranial berry aneurysm, see ANIB1 (105800).
Telangiectasia, hereditary hemorrhagic, type 2
MedGen UID:
324960
Concept ID:
C1838163
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.
Vascular hyalinosis
MedGen UID:
376398
Concept ID:
C1848590
Disease or Syndrome
A rare systemic disease characterized by progressive hyalinosis involving capillaries, arterioles and small veins of the digestive tract, kidneys, and retina, associated with idiopathic cerebral calcifications, manifesting with severe diarrhea (with rectal bleeding and malabsorption), nephropathy (with renal failure and systemic hypertension), chorioretinal scarring, and subarachnoid hemorrhage. Poikiloderma and premature greying of the hair may be additionally observed.
Hereditary hemorrhagic telangiectasia type 4
MedGen UID:
341824
Concept ID:
C1857688
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.
Stormorken syndrome
MedGen UID:
350028
Concept ID:
C1861451
Disease or Syndrome
Stormorken syndrome is an autosomal dominant disorder characterized by mild bleeding tendency due to platelet dysfunction, thrombocytopenia, anemia, asplenia, tubular aggregate myopathy, congenital miosis, and ichthyosis. Additional features may include headache or recurrent stroke-like episodes (summary by Misceo et al., 2014).
Cerebral amyloid angiopathy, APP-related
MedGen UID:
414044
Concept ID:
C2751536
Disease or Syndrome
Two types of hereditary cerebral amyloid angiopathy, known as familial British dementia and familial Danish dementia, are characterized by dementia and movement problems. Strokes are uncommon in these types. People with the Danish type also have clouding of the lens of the eyes (cataracts) and deafness.\n\nStrokes are rare in people with the Arctic type of hereditary cerebral amyloid angiopathy, in which the first sign is usually memory loss that then progresses to severe dementia. Strokes are also uncommon in individuals with the Iowa type. This type is characterized by memory loss, problems with vocabulary and the production of speech, personality changes, and involuntary muscle twitches (myoclonus).\n\nThe first sign of the Icelandic type of hereditary cerebral amyloid angiopathy is typically a stroke followed by dementia. Strokes associated with the Icelandic type usually occur earlier than the other types, with individuals typically experiencing their first stroke in their twenties or thirties.\n\nPeople with the Flemish and Italian types of hereditary cerebral amyloid angiopathy are prone to recurrent strokes and dementia. Individuals with the Piedmont type may have one or more strokes and typically experience impaired movements, numbness or tingling (paresthesias), confusion, or dementia.\n\nThe Dutch type of hereditary cerebral amyloid angiopathy is the most common form. Stroke is frequently the first sign of the Dutch type and is fatal in about one third of people who have this condition. Survivors often develop dementia and have recurrent strokes. About half of individuals with the Dutch type who have one or more strokes will have recurrent seizures (epilepsy).\n\nThere are many different types of hereditary cerebral amyloid angiopathy. The different types are distinguished by their genetic cause, which determines whether areas of the brain other than blood vessels are affected, and the signs and symptoms that occur. The various types of hereditary cerebral amyloid angiopathy are named after the regions where they were first diagnosed.\n\nHereditary cerebral amyloid angiopathy is a condition characterized by an abnormal buildup of protein clumps called amyloid deposits in the blood vessels in the brain, causing vascular disease (angiopathy). People with hereditary cerebral amyloid angiopathy often have progressive loss of intellectual function (dementia), stroke, and other neurological problems starting in mid-adulthood. Due to neurological decline, this condition is typically fatal in one's sixties, although there is variation depending on the severity of the signs and symptoms. Most affected individuals die within a decade after signs and symptoms first appear, although some people with the disease have survived longer.
Aneurysm-osteoarthritis syndrome
MedGen UID:
462437
Concept ID:
C3151087
Disease or Syndrome
Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, and cervical spine malformation and/or instability), craniofacial features (hypertelorism, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.
Telangiectasia, hereditary hemorrhagic, type 1
MedGen UID:
1643786
Concept ID:
C4551861
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.
Combined immunodeficiency due to DOCK8 deficiency
MedGen UID:
1648410
Concept ID:
C4722305
Disease or Syndrome
Hyper-IgE syndrome-2 with recurrent infections (HIES2) is an autosomal recessive immunologic disorder characterized by recurrent staphylococcal infections of the skin and respiratory tract, eczema, elevated serum immunoglobulin E, and hypereosinophilia. It is distinguished from autosomal dominant HIES1 (147060) by the lack of connective tissue and skeletal involvement (Renner et al., 2004). For a discussion of genetic heterogeneity of hyper-IgE syndrome, see 147060. See also TYK2 deficiency (611521), a clinically distinct disease entity that includes characteristic features of both autosomal recessive HIES2 and mendelian susceptibility to mycobacterial disease (MSMD; 209950) (Minegishi et al., 2006).
Aneurysm, intracranial berry, 12
MedGen UID:
1684660
Concept ID:
C5231484
Disease or Syndrome
Rupture of an intracranial aneurysm (IA), an outpouching or sac-like widening of a cerebral artery, leads to a subarachnoid hemorrhage (SAH), a sudden-onset disease that can lead to severe disability and death. Several risk factors such as smoking, hypertension, and excessive alcohol intake are associated with subarachnoid hemorrhage (summary by Krischek and Inoue, 2006).
Intellectual developmental disorder, x-linked, syndromic 37
MedGen UID:
1854940
Concept ID:
C5935567
Disease or Syndrome
X-linked syndromic intellectual developmental disorder-37 (MRXS37) is a developmental disorder showing phenotypic variability and variable severity. Male mutation carriers tend to be more severely affected than female mutation carriers, some of whom may even be asymptomatic. In general, the disorder is characterized by global developmental delay with delayed walking, speech delay, impaired intellectual development that ranges from borderline low to moderate, and behavioral abnormalities, such as autism and sleeping difficulties. Many patients are able to attend mainstream schools with assistance and work under supervision. Additional more variable features include sensorineural hearing loss, ocular anomalies, feeding difficulties, dysmorphic facial features, inguinal and umbilical hernia, genitourinary defects, congenital heart defects, musculoskeletal anomalies, and endocrine dysfunction, such as hypogonadism or hyperparathyroidism (Shepherdson et al., 2024).

Professional guidelines

PubMed

Treggiari MM, Rabinstein AA, Busl KM, Caylor MM, Citerio G, Deem S, Diringer M, Fox E, Livesay S, Sheth KN, Suarez JI, Tjoumakaris S
Neurocrit Care 2023 Aug;39(1):1-28. Epub 2023 May 18 doi: 10.1007/s12028-023-01713-5. PMID: 37202712
Osgood ML
Curr Neurol Neurosci Rep 2021 Jul 26;21(9):50. doi: 10.1007/s11910-021-01136-9. PMID: 34308493
Chung DY, Olson DM, John S, Mohamed W, Kumar MA, Thompson BB, Rordorf GA
Curr Neurol Neurosci Rep 2019 Nov 26;19(12):94. doi: 10.1007/s11910-019-1009-9. PMID: 31773310Free PMC Article

Recent clinical studies

Etiology

Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, Hänggi D, Hetts SW, Ifejika NL, Johnson R, Keigher KM, Leslie-Mazwi TM, Lucke-Wold B, Rabinstein AA, Robicsek SA, Stapleton CJ, Suarez JI, Tjoumakaris SI, Welch BG
Stroke 2023 Jul;54(7):e314-e370. Epub 2023 May 22 doi: 10.1161/STR.0000000000000436. PMID: 37212182
Rinkel GJ, Ruigrok YM
Int J Stroke 2022 Jan;17(1):30-36. Epub 2021 Jun 17 doi: 10.1177/17474930211024584. PMID: 34042530Free PMC Article
Griswold DP, Fernandez L, Rubiano AM
J Neurotrauma 2022 Jan;39(1-2):35-48. Epub 2021 Apr 22 doi: 10.1089/neu.2021.0007. PMID: 33637023Free PMC Article
Hackenberg KAM, Hänggi D, Etminan N
Stroke 2018 Sep;49(9):2268-2275. doi: 10.1161/STROKEAHA.118.021030. PMID: 30355003
Abraham MK, Chang WW
Emerg Med Clin North Am 2016 Nov;34(4):901-916. doi: 10.1016/j.emc.2016.06.011. PMID: 27741994

Diagnosis

Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, Hänggi D, Hetts SW, Ifejika NL, Johnson R, Keigher KM, Leslie-Mazwi TM, Lucke-Wold B, Rabinstein AA, Robicsek SA, Stapleton CJ, Suarez JI, Tjoumakaris SI, Welch BG
Stroke 2023 Jul;54(7):e314-e370. Epub 2023 May 22 doi: 10.1161/STR.0000000000000436. PMID: 37212182
Muehlschlegel S
Continuum (Minneap Minn) 2018 Dec;24(6):1623-1657. doi: 10.1212/CON.0000000000000679. PMID: 30516599
Fernando SM, Perry JJ
CMAJ 2017 Nov 20;189(46):E1421. doi: 10.1503/cmaj.170893. PMID: 29158456Free PMC Article
Long B, Koyfman A, Runyon MS
Emerg Med Clin North Am 2017 Nov;35(4):803-824. Epub 2017 Aug 24 doi: 10.1016/j.emc.2017.07.001. PMID: 28987430
Abraham MK, Chang WW
Emerg Med Clin North Am 2016 Nov;34(4):901-916. doi: 10.1016/j.emc.2016.06.011. PMID: 27741994

Therapy

Wolf S, Mielke D, Barner C, Malinova V, Kerz T, Wostrack M, Czorlich P, Salih F, Engel DC, Ehlert A, Staykov D, Alturki AY, Sure U, Bardutzky J, Schroeder HWS, Schürer L, Beck J, Juratli TA, Fritsch M, Lemcke J, Pohrt A, Meyer B, Schwab S, Rohde V, Vajkoczy P; EARLYDRAIN Study Group
JAMA Neurol 2023 Aug 1;80(8):833-842. doi: 10.1001/jamaneurol.2023.1792. PMID: 37330974Free PMC Article
Treggiari MM, Rabinstein AA, Busl KM, Caylor MM, Citerio G, Deem S, Diringer M, Fox E, Livesay S, Sheth KN, Suarez JI, Tjoumakaris S
Neurocrit Care 2023 Aug;39(1):1-28. Epub 2023 May 18 doi: 10.1007/s12028-023-01713-5. PMID: 37202712
Geraldini F, De Cassai A, Diana P, Correale C, Boscolo A, Zampirollo S, Disarò L, Carere A, Cacco N, Navalesi P, Munari M
Neurocrit Care 2022 Jun;36(3):1071-1079. Epub 2022 Apr 13 doi: 10.1007/s12028-022-01493-4. PMID: 35419702
Pontes FGB, da Silva EM, Baptista-Silva JC, Vasconcelos V
Cochrane Database Syst Rev 2021 May 10;5(5):CD013312. doi: 10.1002/14651858.CD013312.pub2. PMID: 33971026Free PMC Article
Tabrizchi R
Curr Opin Investig Drugs 2000 Nov;1(3):347-54. PMID: 11249718

Prognosis

Lauzier DC, Jayaraman K, Yuan JY, Diwan D, Vellimana AK, Osbun JW, Chatterjee AR, Athiraman U, Dhar R, Zipfel GJ
Stroke 2023 May;54(5):1426-1440. Epub 2023 Mar 3 doi: 10.1161/STROKEAHA.122.040072. PMID: 36866673Free PMC Article
Rufus P, Moorthy RK, Joseph M, Rajshekhar V
Neurol India 2021 Nov-Dec;69(Supplement):S420-S428. doi: 10.4103/0028-3886.332264. PMID: 35102998
Long B, Koyfman A, Runyon MS
Emerg Med Clin North Am 2017 Nov;35(4):803-824. Epub 2017 Aug 24 doi: 10.1016/j.emc.2017.07.001. PMID: 28987430
Portegies ML, Koudstaal PJ, Ikram MA
Handb Clin Neurol 2016;138:239-61. doi: 10.1016/B978-0-12-802973-2.00014-8. PMID: 27637962
Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group
Lancet 2005 Sep 3-9;366(9488):809-17. doi: 10.1016/S0140-6736(05)67214-5. PMID: 16139655

Clinical prediction guides

English S, Van Walraven CVW
Clin Invest Med 2022 Sep 21;45(3):E9-13. doi: 10.25011/cim.v45i3.38874. PMID: 36149053
Sengupta J, Alzbutas R
Biomed Res Int 2022;2022:5416726. Epub 2022 Jan 27 doi: 10.1155/2022/5416726. PMID: 35111845Free PMC Article
Oda S, Shimoda M, Hirayama A, Imai M, Komatsu F, Shigematsu H, Nishiyama J, Hotta K, Matsumae M
J Neurosurg 2018 Feb;128(2):499-505. Epub 2017 Feb 10 doi: 10.3171/2016.10.JNS161964. PMID: 28186448
Karceski S
Neurology 2017 Apr 25;88(17):e179-e181. doi: 10.1212/WNL.0000000000003880. PMID: 28438851
Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, MacDonald RL, Mayer SA
Neurosurgery 2006 Jul;59(1):21-7; discussion 21-7. doi: 10.1227/01.neu.0000243277.86222.6c. PMID: 16823296

Recent systematic reviews

Pontes JPM, Santos MDC, Gibram FC, Rodrigues NMV, Cavalcante-Neto JF, Barros ADM, Solla DJF
Neurosurgery 2023 Dec 1;93(6):1208-1219. Epub 2023 Jul 18 doi: 10.1227/neu.0000000000002601. PMID: 37462365
Siddiqi TJ, Usman MS, Rashid AM, Javaid SS, Ahmed A, Clark D 3rd, Flack JM, Shimbo D, Choi E, Jones DW, Hall ME
J Am Heart Assoc 2023 Jul 18;12(14):e029355. Epub 2023 Jul 8 doi: 10.1161/JAHA.122.029355. PMID: 37421281Free PMC Article
Geraldini F, De Cassai A, Diana P, Correale C, Boscolo A, Zampirollo S, Disarò L, Carere A, Cacco N, Navalesi P, Munari M
Neurocrit Care 2022 Jun;36(3):1071-1079. Epub 2022 Apr 13 doi: 10.1007/s12028-022-01493-4. PMID: 35419702
Pontes FGB, da Silva EM, Baptista-Silva JC, Vasconcelos V
Cochrane Database Syst Rev 2021 May 10;5(5):CD013312. doi: 10.1002/14651858.CD013312.pub2. PMID: 33971026Free PMC Article
Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, Algra A
JAMA Neurol 2019 May 1;76(5):588-597. doi: 10.1001/jamaneurol.2019.0006. PMID: 30659573Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...